Forward Pharma A/S (FWP) Stock Analysis

What Forward Pharma A/S does

Forward Pharma A/S currently conducts no significant business activities. In its prior operations, the company functioned as a biopharmaceutical firm. It dedicated its efforts to advancing FP187, its exclusive formulation of dimethyl fumarate, designed to address inflammatory and neurological disorders. Forward Pharma A/S was founded in 2005 and maintains its corporate headquarters in Copenhagen, Denmark.

Key metrics

ETFs linked to FWP

Broad-market and Healthcare sector ETFs an investor holding Forward Pharma A/S is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how FWP fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Forward Pharma A/S?

Forward Pharma A/S trades under the ticker FWP on NASDAQ.

Which exchange is FWP listed on?

FWP is listed on NASDAQ.

What sector does Forward Pharma A/S operate in?

Forward Pharma A/S is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze FWP in a portfolio?

PortView shows FWP's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.